Get to know our faculty members, and gain further information surrounding their backgrounds and expertise, through multimedia videos.
CMHC Chair George Bakris and Senior Planning Committee Member Clyde Yancy discuss the key highlights of the 2020 CMHC West presentation "Advances in the Prevention and Treatment of HF"
CMHC Chair Christie M. Ballantyne, MD and faculty member Marc S. Sabatine, MD share highlights on the 13th Annual CMHC in Boston.
CMHC Faculty member, Jason Tregellas, MD shares on the impact of exercise on mental and cardiovascular health.
CMHC Chair Robert H. Eckel, M.D. leads a panel discussion on various approaches to the treatment of type 2 diabetes.
CMHC faculty member Alan Chait, M.D. shares insight on the use of animal models in researching cardiovascular inflammation.
CMHC West Chair, Ken Fujioka, MD shares on the importance of emphasizing weight loss in the management of type 2 diabetes.
CMHC Faculty members discuss the latest clinical research in cardiometabolic health.
CMHC Faculty members discuss the importance of addressing co-morbidities in heart disease.
CMHC Faculty Member discusses the newest therapeutic strategies in cardiometabolic health with nephrologist Lance Sloan, MD and endocrinologist Yehuda Handelsman, MD.
CMHC Chair, Keith C. Ferdinand, MD leads panel discussion with faculty members, JoAnn Lindenfeld, MD and Alanna A. Morris, MD on the current state of HFpEF intervention options.
CMHC faculty members Matthew Stryker and Kim Birtcher lead a discussion on prior authorization.
CMHC Chair Robert Eckel and Senior Planning Committee member Keith Ferdinand discuss the importance of cardiometabolic health and the importance of attending the Annual Cardiometabolic Health Congress.
CMHC faculty members Kate Kirley and Janet Williams lead a discussion on their AMA workshops
CMHC faculty members Irl Hirsch and Anne Peters talk about CGM management
CMHC Chair Robert Eckel and CMHC faculty member Robert Kushner lead a discussion on obesity management
CMHC Chair Jay Skyler and CMHC Keynote presenter C. Ronald Kahn discuss Dr. Kahn's keynote presentation regarding his work with insulin receptors and insulin resistance in diabetes and obesity
CMHC Senior Planning Committee member Keith Ferdinand and CMHC faculty member Alanna Morris, and JoAnn Lindenfeld discuss the importance of HFpEF management
CMHC West Chair Ken Fujioka, M.D. and CMHC West Keynote speaker Spero M. Manson, PhD discuss the impact of the Special Diabetes Program for Indians.
CMHC Chair, Christie M. Ballantyne, MD and Salim Virani, MD, PhD discuss the latest cholesterol guidelines
CMHC West Chair Ken Fujioka, M.D. leads a spirited panel discussion on the current state of dietary approaches for cardiometabolic health with Alice Lichtenstein, DSc, Andrew Freeman, MD and Kim A. Williams, Sr., MD.
CMHC Chair, Christie M. Ballantyne, MD and Senior Planning Committee member Deepak L. Bhatt, MD, MPH discuss antithrombotics in diabetic patients.
CMHC Chair, Christie M. Ballantyne, MD and Senior Planning Committee member Pamela B. Morris, MD discuss the new era of LDL-C lowering.
CMHC Chair, George L. Bakris, MD and Senior Planning Committee member Clyde W. Yancy, MD, MSc, MACP discuss gender equality and race issues in the treatment of heart failure.
CMHC Chair, Jay S. Skyler and Irl B. Hirsch, MD discuss insulin access and cost
CMHC Chair, Jay S. Skyler and Lawrence Blonde, MD discuss the updates on cardiovascular outcomes trials.
CMHC Women’s Health Summit Chair, Pamela B. Morris, MD and Ralph La Forge, MSc, FNLA, CLS discuss cardiometabolic risk management in American Indians and Alaska Native Women.
CMHC Women’s Health Summit Chair, Pamela B. Morris, MD and Deepak L. Bhatt, MD, MPH discuss the role of aspirin therapy for CVD prevention in women.
CMHC Chair Robert H. Eckel, M.D., and faculty member Christos S. Mantzoros, MD, discuss how fatty liver diseases such as NASH, NAFLD, etc., are directly related to cardiometabolic diseases.
Drs. Lawrence Blonde and Eric Peterson discuss the role of Big Data and Real-World Evidence in Cardiometabolic Health.
Drs. Peter McCullough, Gurusher Panjrath, and Andy Lee discuss how Iron deficiency is underdiagnosed and is common in heart failure.
CMHC Chair George Bakris and experts Biff Palmer and Matthew Weir discuss long-term management of hyperkalemic patients with HF and CKD.
Drs. Jessup, Butler, Morris and Piña discuss the challenges in diagnosis and management of heart failure with preserved ejection fraction.
A two-part series with CMHC Chair George Bakris and faculty, Raymond Townsend and Michael Weber who discuss integrating the latest hypertension guidelines and addressing the gaps in management.
Drs. Christie Ballantyne and Leslie Cho discuss how to manage patients with statin intolerance.
Dr. Blumenthal, who was the part of cholesterol guidelines writing group and co-chair of recent ACC/ AHA prevention guidelines, reviews these guidelines with CMHC Chair Dr. Ballantyne.
CMHC Chair Robert Eckel asks the experts Dr. Devries and Dr. Wyatt to discuss the importance of overall dietary patterns and lifestyle modifications to improve cardiometabolic health.
Drs. Ballantyne and Khera discuss the role of genomics for the prevention of cardiometabolic diseases.
Drs. Bakris and Butler discuss the intersection of heart failure, kidney disease and diabetes – Focused mainly on recent clinical trials such as the DAPA-HF trial.